Previous 10 | Next 10 |
LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference from ...
To ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commitment to the EMEA market, Prenetics Globa ( NASDAQ: PRE ) names Dr. Bayju Thakar as CEO and shall join the board of directors for Prenetics EMEA, a wholly owned subsidiar...
LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a c...
3 Ways That Penny Stocks Can Make You Money in 2023 Penny stocks can also be a great way to make money if done correctly. Before you invest in a penny stock, it is important to do research into the company and understand how their stock works. This means understanding the risks associated wit...
Shares of Prenetics Global Limited (NASDAQ: PRE) were skyrocketing 27.8% higher as of 11:12 a.m. ET on Tuesday. The huge gain came after the company announced that the U.S. Food and Drug Administration (FDA) cleared ACT Genomics' ACTOnco comprehensive genomic profiling test for solid ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: ventdusud / Shutterstock.com We’re starting off the day with an overview of the biggest pre-market stock movers for Tuesday! Moving stocks this morning are acquisition deals, clinical trial data, a failed...
Prenetics Global ( NASDAQ: PRE ) said ACT Genomics received clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco, the company's genomic profiling test for solid tumors. Prenetics noted that it had recently completed a majority stake acquisition of ACT Genomics. ...
Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology market FDA market authorization advances personalized cancer care in Asia Clearance sets the stage for continued R&D investment into early...
Acquisition to bring germline and somatic testing, cell-free DNA-based (liquid biopsy), and tissue-genomic profiling onto a single platform Cancer genomics testing is now standard practice for cancer care and has shown to be highly successful such as Foundation One (acquired by Roche), Grail ...
LONDON and HONG KONG, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and ...
News, Short Squeeze, Breakout and More Instantly...
Prenetics Global Limited Company Name:
PRE Stock Symbol:
NASDAQ Market:
Prenetics Global Limited Website:
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
--News Direct-- As the global population ages and the prevalence of chronic diseases rises, there is an increasing demand for innovative solutions that can enhance prevention, diagnosis, and treatment. The health sciences industry is undergoing a significant transformation, thanks to advances...
Beckham becomes a strategic investor in Prenetics Beckham and Prenetics are co-founding partners for IM8, a new health and wellness brand LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announc...